These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12225605)

  • 1. Clinical review: use of vancomycin in haemodialysis patients.
    Launay-Vacher V; Izzedine H; Mercadal L; Deray G
    Crit Care; 2002 Aug; 6(4):313-6. PubMed ID: 12225605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosage recommendation of vancomycin during haemodialysis with highly permeable membranes.
    Zoer J; Schrander-van der Meer AM; van Dorp WT
    Pharm World Sci; 1997 Aug; 19(4):191-6. PubMed ID: 9297732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal Function Descriptors in Neonates: Which Creatinine-Based Formula Best Describes Vancomycin Clearance?
    Bhongsatiern J; Stockmann C; Yu T; Constance JE; Moorthy G; Spigarelli MG; Desai PB; Sherwin CM
    J Clin Pharmacol; 2016 May; 56(5):528-40. PubMed ID: 26412385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmented Renal Clearance Using Population-Based Pharmacokinetic Modeling in Critically Ill Pediatric Patients.
    Avedissian SN; Bradley E; Zhang D; Bradley JS; Nazer LH; Tran TM; Nguyen A; Le J
    Pediatr Crit Care Med; 2017 Sep; 18(9):e388-e394. PubMed ID: 28640009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
    Hermida J; Tutor JC
    Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.
    Joy MS; Matzke GR; Frye RF; Palevsky PM
    Am J Kidney Dis; 1998 Jun; 31(6):1019-27. PubMed ID: 9631848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin-resistant enterococcus in end-stage renal disease.
    Brady JP; Snyder JW; Hasbargen JA
    Am J Kidney Dis; 1998 Sep; 32(3):415-8. PubMed ID: 9740157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin: pharmacokinetics and administration regimens in neonates.
    de Hoog M; Mouton JW; van den Anker JN
    Clin Pharmacokinet; 2004; 43(7):417-40. PubMed ID: 15139793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of drug therapy in chronic dialysis patients.
    Cutler RE; Christopher TG; Forrey AW; Blair AD
    Kidney Int Suppl; 1975 Jan; (2):16-22. PubMed ID: 1057676
    [No Abstract]   [Full Text] [Related]  

  • 10. [Measurements of vancomycin concentrations in the blood - a method of personalization the antibiotic therapy in patients with chronic kidney disease].
    Pondel J; Krajewski P; Królikowska N; Tobiasz A; Augustyniak-Bartosik H; Hurkacz M
    Pol Merkur Lekarski; 2017 Apr; 42(250):145-150. PubMed ID: 28530212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines.
    Kullar R; Leonard SN; Davis SL; Delgado G; Pogue JM; Wahby KA; Falcione B; Rybak MJ
    Pharmacotherapy; 2011 May; 31(5):441-8. PubMed ID: 21923425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin pharmacokinetics, renal handling, and nonrenal clearances in normal human subjects.
    Golper TA; Noonan HM; Elzinga L; Gilbert D; Brummett R; Anderson JL; Bennett WM
    Clin Pharmacol Ther; 1988 May; 43(5):565-70. PubMed ID: 3365918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of vancomycin in neonates of postconceptional age less than or equal to 32 weeks].
    Ginovart Galiana G; Mangues Bafalluy MA; Demestre Guasch X; Farré Riba R; Lopes Santos AP; Altirriba Valls O
    An Esp Pediatr; 1996 Aug; 45(2):167-71. PubMed ID: 8967647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rebound of plasma vancomycin levels after haemodialysis with highly permeable membranes.
    Böhler J; Reetze-Bonorden P; Keller E; Kramer A; Schollmeyer PJ
    Eur J Clin Pharmacol; 1992; 42(6):635-9. PubMed ID: 1623904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of vancomycin in normal subjects and in patients with reduced renal function.
    Moellering RC; Krogstad DJ; Greenblatt DJ
    Rev Infect Dis; 1981; 3 suppl():S230-5. PubMed ID: 7342286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of serum creatinine measurements on GFR estimation and vancomycin dosing in children.
    Neuman G; Nulman I; Adeli K; Koren G; Colantonio DA; Helldén A
    J Clin Pharmacol; 2014 Jul; 54(7):785-91. PubMed ID: 24596064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amikacin maturation model as a marker of renal maturation to predict glomerular filtration rate and vancomycin clearance in neonates.
    Zhao W; Biran V; Jacqz-Aigrain E
    Clin Pharmacokinet; 2013 Dec; 52(12):1127-34. PubMed ID: 24027065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of methods to estimate glomerular filtration rate versus actual drug clearance in patients with chronic spinal cord injury.
    Lee JP; Dang AT
    Spinal Cord; 2011 Dec; 49(12):1158-63. PubMed ID: 21788951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A physiological approach to renal clearance: From premature neonates to adults.
    Holford N; O'Hanlon CJ; Allegaert K; Anderson B; Falcão A; Simon N; Lo YL; Thomson AH; Sherwin CM; Jacqz-Aigrain E; Llanos-Paez C; Hennig S; Mockus L; Kirkpatrick C
    Br J Clin Pharmacol; 2024 Apr; 90(4):1066-1080. PubMed ID: 38031322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Approach to Optimise Therapeutic Vancomycin Dosage in a Haemodialysis Population.
    Gunning H; Taylor G; Smyth A; Mellotte G; Fennell J; Murphy P; Lavin P; Wall C
    Ir Med J; 2016 Oct; 109(9):465. PubMed ID: 28125179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.